Propulsid Suits Dismissed As Case Draws To A Close
The massive multidistrict litigation against drug maker Johnson & Johnson and its subsidiary Janssen Pharmaceutica over heartburn drug Propulsid is wrapping up as thousands of plaintiffs become eligible for a cut...To view the full article, register now.
Already a subscriber? Click here to view full article